GaStroEsophageal effeCt of indobUfen Versus aspiRin in Patients Undergoing Dual antiplatElet Therapy
Condition(s):Coronary Artery Disease; Gastroesophageal Reflux DiseaseLast Updated:October 16, 2019Unknown status
Hide Studies Not Open or Pending
Condition(s):Coronary Artery Disease; Gastroesophageal Reflux DiseaseLast Updated:October 16, 2019Unknown status
Condition(s):Intermittent ClaudicationLast Updated:January 28, 2014Completed
Condition(s):Acute Respiratory Distress SyndromeLast Updated:March 13, 2019Terminated
Condition(s):Cardiovascular Disease; Interventional CardiologyLast Updated:January 13, 2021Completed
Condition(s):PreeclampsiaLast Updated:November 13, 2020Withdrawn
Condition(s):Tuberous Sclerosis Complex; Aspirin; Epilepsy; Cognitive Decline; Skin LesionsLast Updated:June 9, 2020Unknown status
Condition(s):Blood Loss, Surgical; Intraoperative Complications; Re-operation Rates in Patients With Aspirin TreatmentLast Updated:March 19, 2024Withdrawn
Condition(s):Coronary ArteriosclerosisLast Updated:May 14, 2013Completed
Condition(s):Coronary Artery Disease; Off-pump Coronary Artery Bypass; AspirinLast Updated:December 31, 2010Unknown status
Condition(s):Gastrointestinal HemorrhageLast Updated:March 9, 2012Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.